Decitabine in myelodysplastic syndromes: viewpoints

Drugs. 2006;66(7):959-60. doi: 10.2165/00003495-200666070-00013.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antimetabolites, Antineoplastic / chemistry
  • Antimetabolites, Antineoplastic / pharmacokinetics
  • Antimetabolites, Antineoplastic / therapeutic use
  • Area Under Curve
  • Azacitidine / adverse effects
  • Azacitidine / analogs & derivatives*
  • Azacitidine / pharmacokinetics
  • Azacitidine / therapeutic use
  • Clinical Trials as Topic
  • Decitabine
  • Humans
  • Molecular Structure
  • Myelodysplastic Syndromes / drug therapy*
  • Treatment Outcome

Substances

  • Antimetabolites, Antineoplastic
  • Decitabine
  • Azacitidine